Trial intelligence / Profile preview

Esketamine plus propofol vs sufentanil plus propofol in outpatient hysteroscopic surgery

ChiCTR2100052600Phase 4Recruiting

Sponsor
Hengyang Maternal and Child Health Care Hospital
Start
Dec 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine, sufentanil and propofol (4 arms), sponsored by Hengyang Maternal and Child Health Care Hospital. Primary endpoint: Waking time. Started Dec 2020; status: recruiting.

02

Drugs

esketaminesufentanilpropofol

Beyond the preview

Go deeper on ChiCTR2100052600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call